IVD MEDICAL (01931) announced that the board of directors believes purchasing and holding cryptocurrencies represents a crucial initiative for the group to strengthen its Ethereum (ETH) reserve treasury and accelerate the development of its ivd.xyz exchange ecosystem business layout. This move is also considered an important component of the group's asset allocation strategy.
After careful consideration, the board proposes to seek prior shareholder approval for the purchase authorization. This would authorize the board to conduct potential cryptocurrency purchases within a 36-month period starting from the date when the ordinary resolution regarding the purchase authorization and potential cryptocurrency acquisitions is formally passed at the extraordinary general meeting, with total purchases not exceeding HK$3 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.